Koyfin Home > Directory > Health Care > Adamas Pharma > Repurchase of Common Stock

Adamas Pharma Repurchase of Common Stock Chart (ADMS)

Adamas Pharma annual/quarterly Repurchase of Common Stock from 2013 to 2014.
  • Adamas Pharma Repurchase of Common Stock for the quarter ending December 12, 2014 was $0m
  • Adamas Pharma Repurchase of Common Stock for the last 12 months ending September 09, 2015 was $0m a 0.00% decrease of 0m year over year
Other Cash Flow Metrics:
  • Adamas Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-24m a -5.06% increase of 1m year over year
  • Adamas Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-33m a 50.48% decrease of -17m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Repurchase of Common Stock Data

12/2014$0m
09/2014$0m
12/2013$0m

Annual ADMS Repurchase of Common Stock Data

2014$0m